Reg. no. 5593126955 · Research and experimental development on biotechnology · SOLNA
Cellcolabs AB is registered with the legal form Limited company, is based in SOLNA and is active in Research and experimental development on biotechnology. Revenue for 2025 was 44.2 MSEK.
Fiscal year ending 2025-12-31 · Amounts in SEK
Net revenue
44.2 MSEK
▲ +189%Operating result
-97.3 MSEK
▼ −5%Net result
-97.6 MSEK
▼ −6%Employees (annual report)
68
▲ +5%Total assets
124 MSEK
Equity
109 MSEK
Equity ratio
87.8 %
Profit margin
−220.9 %
One or more values below fall outside the ranges we normally see. These figures usually come straight from the company's filed annual report — check the original document (available above) before relying on them.
MSEK
Cellcolabs AB increased net sales by 190.1 % to 44.2 MSEK in 2025. The company’s operating margin went from -606.9 % to -220.4 % in 2025. Cash holdings amounted to roughly 60.1 % of total assets for 2025. The company’s 68 employees corresponded to net sales of roughly 650 kSEK per employee in 2025.
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Cellcolabs AB's reg. no. is 5593126955.
Cellcolabs AB reported revenue of 44.2 MSEK for the fiscal year 2025.
No — Cellcolabs AB reported a net result of -97.6 MSEK for 2025.
Cellcolabs AB had 68 employees as of the most recently reported period (2025).
Cellcolabs AB is registered under Research and experimental development on biotechnology.
Cellcolabs AB is based in SOLNA.
arkivnord